Clario Innovation Theater: Striking the Balance – Integrating Patient-Friendly Solutions Without Compromising Quality Science
Date: Tuesday, June 17, 2025
Time: 9:45am – 10:15am EDT
Abstract:
There is a critical balance to be struck, ensuring that study designs and digital endpoint solutions are not overburdensome to participants, but are still sufficiently robust to generate the quality data required to determine drug efficacy, safety, and impact to quality of life. In this engaging panel, we’ll review why maintaining patient focus is essential for success in today’s clinical studies, and how to do so successfully while maintaining the scientific rigor needed to achieve study goals.
EVP & Chief Medical Officer at Clario
Dr. Todd Rudo provides medical and scientific leadership across Clario. He has nearly 20 years of clinical cardiology & pharmaceutical research experience, with a career predominantly focused on drug safety. Dr. Rudo has board certifications in cardiology, cardiac electrophysiology, nuclear cardiology, adult echocardiography & internal medicine. His team provides expert consulting to clients on scientific & regulatory strategy, and ensures Clario’s product portfolio is scientifically robust, generating high-quality clinical trial endpoint data. He focuses on applying innovative technologies to improve the scientific rigor of clinical trials, while maintaining focus on the customer experience, including minimizing patient and site burden.
Chief Information, Technology and Product Officer at Clario
Always striving for excellence, Jay heads up Clario’s development, information technology and strategic sourcing initiatives. With over 25 years’ experience of working as a global technology leader, Jay has a wealth of knowledge which helps drive changes that are critical to managing data protection. An expert in improving and implementing data policies, Jay is well placed to ensure the complete privacy and protection of data belonging to Clario’s customers and patients.
Director, eCOA Science and Consulting at Clario
Dr. Kelly Dumais is a scientist with over 13 years of experience in behavioral and life science research. She has expertise in the implementation of electronic clinical outcome assessments (eCOA) and the development and validation of patient-reported outcomes (PROs) to support labeling claims. She is currently the Director of eCOA Science and Consulting at Clario, a global data and technology company that helps to minimize risk in clinical trials. She consults on best practices for questionnaire design and eCOA design/use to drive data integrity and patient engagement and develops custom site rater training and participant training for improving accuracy in COA reporting and improving inter-and intra-rater reliability.
Chief Patient Officer at Parexel
Stacy is a globally recognized advocate in patient communities, ensuring patients/caregivers voice their experience & feedback at early stages to improve drug development. She promotes clinical research accessibility for people with disabilities, for equal access to better treatments, improved outcomes & cures. Stacy is an award-winning pharma executive with 25 years experience in sales, marketing, training, operations & physician practice management. She is a frequent speaker & influencer, advocating patient involvement in research & co-chairs the American Cancer Society Northeast Region. She has a bachelor’s degree in labor/industrial relations (Penn State) & master’s degree in both health and business administration (Univ. of Pittsburgh)
Complete this form and we will reach out soon to schedule a time to connect at the event.
If you are a company wishing to collaborate with us, please stop by our booth during the conference to talk with our team.